| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-829 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate |
1998-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2001-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2001514212-A |
| titleOfInvention |
Biphasic lipid vesicle composition for transdermal immunogen administration |
| abstract |
(57) SUMMARY A composition for transdermal immunogen administration is described. The immunogen is trapped in lipid vesicles having an oil-in-water emulsion in the central core compartment. The vesicle is administered transdermally to elicit an immune response in the subject. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008179561-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016136732-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006503072-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014193817-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018028796-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107405312-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107405312-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10543347-B2 |
| priorityDate |
1997-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |